山莨菪碱治疗重症淤胆型肝炎的观察  

Clinical Investigation of Anisodamine in Treatment of Severe Cholestatic Hepatitis

作　　者：石李金 黄仑峰 

机构地区：[1]黄梅县人民医院,黄梅435500

出　　处：《中国医药导刊》2010年第6期975-975,共1页Chinese Journal of Medicinal Guide

摘　　要：目的:使用山莨菪碱(654-2)治疗重症淤胆型肝炎,防止其加重或发展为肝硬化。方法:将获选病例分为治疗组和对照组,治疗组加用654-2,余治疗同对照组。结果:治疗组与对照组疗效有显著差异。结论:654-2治疗重症型肝炎疗效显著,可以迅速稳定病情,黄疸消退快,减少肝硬化发生,降低死亡率。使用654-2疗效好,又很价廉,可在基层医院推广。Objective： To evaluate the clinical effect of anisodamine （654-2） in treatment of cholestatic hepatitis. Methods： 46 cholestatic hepatitis patients were randomly divided into two groups, 654-2 treatment group（n=25） and the control group（n=21）, they have the same treatment except the 65442. Results： the total treatment efficiency rate in the treatment group （89.1%） was higher than that in the control group（68.3% ）, the difference was significant （p〈0.05）. Conclusion： 654-2 have significant effects in the treatment of cholestatic hepatitis, with jaundice dropping fast and mortality rate decline.

关 键 词：山茛菪碱 淤胆型肝炎 治疗 

分 类 号：R593.22[医药卫生—内科学]